Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law) - Image 1

£88.00

Edward Elgar Publishing Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Name: Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)
Brand: Edward Elgar Publishing
Price: 88.0 GBP
Availability: InStock

Law

This is the most expensive it has ever been. Walk away.

£88 today · previous high £88 · all-time low £70

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £70 (18 days, 51.4%)

Price range: £70 - £88

Price levels: 2 different prices over 35 days

Description

This timely book investigates the issue of counterfeit and falsified medicines (CFM) in the EU, identifying that this is a problem that lies at the intersection of three spheres of law - medicine, intellectual property (IP), and criminal law. The book highlights key issues such as infiltration of the legal supply chain and the involvement of organised crime, analysing relevant EU law and demonstrating the challenges of CFM. Using examples from several case studies, Vishv Priya Kohli reveals the gaps in the current legal framework, underlining the particular difficulties created by the interplay between different areas of law as well as the lack of criminal penalties. The author explores areas where improvements have already been made, in particular through the Falsified Medicines Directive, and articulates a number of recommendations to fill in the gaps, for example by harmonizing criminal law and building synergies within law enforcement. Counterfeit and Falsified Medicines in the EU will be of great interest to academics and students in IP, health and medical law, and criminal law in the EU. It will also prove valuable for practitioners and policymakers working in and with enforcement authorities in the EU, as well as those working in the medical field itself. Review ‘The problem of counterfeit medicines, while having its political, economic, medical and social dimension, is also a legal problem. This work is a study of the legal side of counterfeiting from the EU perspective. It provides a comprehensive analysis of the current EU regulatory framework, including medical law, IP law and criminal law. In addition to that, the book also offers detailed case studies of some of the most exciting counterfeiting examples explaining how they were dealt with. A timely and useful work.’ -- Andrej Savin, Copenhagen Business School, Denmark About the Author Vishv Priya Kohli, Assistant Professor, CBS Law, Copenhagen Business School, Denmark

Product Specifications

Brand: Edward Elgar Publishing
Format: hardcover
ASIN: 1788978196
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 07 September 2021
Listed Since: 18 April 2021

Barcode

No barcode data available

Edward Elgar Publishing Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Pharmaceuticals, Corporate Crime and Public Health

Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Guide to EU and UK Pharmaceutical Regulatory Law

Drug Control and International Law (Routledge Research in International Law)

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Blankettstrafgesetze und ihre verfassungsrechtlichen Grenzen: 1 (Juridicum - Schriften zum Wirtschaftsstrafrecht, 1)

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Global Issues in Pharmaceutical Marketing

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Guide to EU Pharmaceutical Regulatory Law

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Pharmaceutical Supply Chain: Drug Quality and Security Act

A Social History of Medicines in the Twentieth Century: To Be Taken Three Times a Day

Contract Manufacturing of Medicines

The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

Routledge Pharmaceutical Industry and Public Policy in India